CANEPA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 12.889
AS - Asia 1.796
NA - Nord America 1.573
Continente sconosciuto - Info sul continente non disponibili 407
SA - Sud America 164
AF - Africa 45
OC - Oceania 8
Totale 16.882
Nazione #
IT - Italia 12.602
US - Stati Uniti d'America 1.483
SG - Singapore 631
CN - Cina 402
VN - Vietnam 305
BD - Bangladesh 232
FR - Francia 128
BR - Brasile 100
HK - Hong Kong 78
FI - Finlandia 34
DE - Germania 33
AR - Argentina 32
CA - Canada 32
GB - Regno Unito 28
IN - India 25
IQ - Iraq 22
JP - Giappone 21
MX - Messico 18
JM - Giamaica 9
PK - Pakistan 9
CH - Svizzera 8
EC - Ecuador 8
ID - Indonesia 8
PH - Filippine 8
RU - Federazione Russa 8
ES - Italia 7
IE - Irlanda 7
MA - Marocco 7
NL - Olanda 7
TN - Tunisia 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
CL - Cile 6
CO - Colombia 6
CR - Costa Rica 6
KR - Corea 6
PY - Paraguay 6
AU - Australia 5
EG - Egitto 5
MY - Malesia 5
TH - Thailandia 5
TR - Turchia 5
UA - Ucraina 5
AZ - Azerbaigian 4
NI - Nicaragua 4
NP - Nepal 4
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
OM - Oman 3
PA - Panama 3
PL - Polonia 3
PR - Porto Rico 3
SV - El Salvador 3
VE - Venezuela 3
AM - Armenia 2
BE - Belgio 2
CM - Camerun 2
GT - Guatemala 2
IR - Iran 2
NZ - Nuova Zelanda 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
FJ - Figi 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
MN - Mongolia 1
MZ - Mozambico 1
NA - Namibia 1
NE - Niger 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
RW - Ruanda 1
SC - Seychelles 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
Totale 16.473
Città #
Genova 6.227
Genoa 4.025
Vado Ligure 1.043
Rapallo 1.034
San Jose 376
Singapore 297
Ashburn 193
Lauterbourg 114
Ho Chi Minh City 104
Council Bluffs 81
Beijing 74
Hong Kong 72
New York 71
Hanoi 60
Santa Clara 36
Los Angeles 35
Bordighera 33
Helsinki 28
Milan 23
Rome 22
Boardman 20
Frankfurt am Main 20
Tokyo 17
Da Nang 16
Mexico City 16
Chicago 13
St Louis 13
Baghdad 12
Dallas 12
Naples 12
Florence 11
Haiphong 11
Buffalo 10
Toronto 9
Charlotte 8
Houston 8
Palermo 8
Queens 8
Zurich 8
Catania 7
Kansas City 7
Kingston 7
Orem 7
San Antonio 7
São Paulo 7
Chennai 6
Hải Dương 6
Quảng Ngãi 6
Tianjin 6
Atlanta 5
Biên Hòa 5
Bologna 5
Cape Coral 5
Dhaka 5
Dublin 5
Miami 5
Padua 5
Paris 5
Philadelphia 5
Quito 5
San José 5
Tampa 5
Tashkent 5
Tucson 5
Turin 5
Cardiff 4
Cleveland 4
Columbus 4
Des Moines 4
Detroit 4
Guangzhou 4
Hangzhou 4
Las Vegas 4
Louisville 4
Madrid 4
Managua 4
Manchester 4
Montreal 4
Nuremberg 4
Phủ Lý 4
Providence 4
Ravenna 4
Sydney 4
Amman 3
Antioch 3
Asunción 3
Austin 3
Baku 3
Bari 3
Brooklyn 3
Buenos Aires 3
Bắc Ninh 3
City of London 3
Corona 3
Dearborn 3
Denver 3
El Sobrante 3
Figino 3
Florianópolis 3
Hempstead 3
Totale 14.449
Nome #
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 269
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 244
Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure 237
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 222
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 217
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly 216
Using unsupervised learning to determine risk level for left ventricular diastolic dysfunction2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 213
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 209
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 204
E / e' ratio and outcome prediction in hypertrophic cardiomyopathy: The influence of outflow tract obstruction 202
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 202
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry 202
Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure 198
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 196
T1 mapping with cardiovascular magnetic resonance: An emerging clinical biomarker 191
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 190
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 187
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy 186
[Cardiac cell therapy: the puzzle is waiting to be solved] 185
Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. 184
Recurrent and residual shunts after patent foramen ovale closure: Results from a long-term transcranial doppler study 183
Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction 182
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 181
Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge 176
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices 171
Early contribution of arterial wave reflection to left ventricular relaxation abnormalities in a community-dwelling population of normotensive and untreated hypertensive men and women. 168
The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. 167
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 166
Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation 162
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 159
What can we learn from pulmonary function testing in heart failure? 158
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 157
Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. 156
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 154
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 154
Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy 153
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 153
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). 152
ECHOCARDIOGRAPHIC AND CLINICAL CORRELATES OF SPECIFIC EARLY REPOLARIZATION SUBTYPES ON ELECTROCARDIOGRAM 152
Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy 149
The association between leptin and depressive symptoms is modulated by abdominal adiposity. 148
Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. 147
Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial 147
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 146
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 146
Multiparametric vs. Inferior Vena Cava-Based Estimation of Right Atrial Pressure 146
Brugada syndrome and syncope: a practical approach for diagnosis and treatment 146
GENDER DIFFERENCES IN EARLY MANIFESTATIONS OF ARTERIAL STIFFNESS: RESULTS FROM THE SARDINIA PROJECT 145
Linking Heart Failure to Cancer 144
The Relationship Between Brain–Heart Autonomic Signaling and Aging: A Gender-Specific Longitudinal Perspective from the Baltimore Longitudinal Study on Aging 143
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis 141
Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device 139
Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging). 138
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 138
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 138
Diagnostic value of ischemia severity at myocardial perfusion imaging in elderly persons with suspected coronary disease 137
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement 136
Human amniotic fluid stem cell secretome protects cardiomyocytes against doxorubicin toxicity 134
Lower mitochondrial energy production of the thigh muscles in patients with low-normal ankle-brachial index 133
Modes of death and prognostic outliers in chronic heart failure 133
Coronary and Cardiac Screening In Liver Transplantation Candidets: A Long Journey with Frequent Identification of Moderate and Severe Coronary Artery Disease 131
Impact of Central Obesity on the Estimation of Carotid-Femoral Pulse Wave Velocity. 130
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease 130
Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study 128
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. 126
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease 123
Echocardiographic Tissue Characterization Using Radiomics in Patients With Transthyretin-Related Cardiac Amyloidosis 121
Bmi and acute kidney injury post transcatheter aortic valve replacement: Unveiling the obesity paradox 121
Indoxyl sulfate: A candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease 120
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 120
Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleagues 119
Cancer in chronic heart failure patients in the GISSI-HF trial 119
Cardiac amyloidosis: a changing epidemiology with open challenges 118
[Italian clinical trials on cardiac cell therapy: where we are and where are we going?] 118
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 117
Longitudinal Association between Serum Uric Acid and Arterial Stiffness: Results from the Baltimore Longitudinal Study of Aging 116
The impossible quest to make cardiac amyloidosis diagnosis easy 116
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis 116
Sometimes they come back: recurrent noncardiac right-to-left shunt after percutaneous patent foramen ovale closure. 115
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 115
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 111
Testing longitudinal data for prognostication in ambulatory heart failure patients with reduced ejection fraction. A proof of principle from the GISSI-HF database 111
C–REACTIVE PROTEIN AS A PREDICTOR OF INTIMAL MEDIA THICKNESS IN A HEALTHY COMMUNITY DWELLING POPULATION OF A BROAD AGE RANGE 110
Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis 110
Pulse wave velocity testing in the Baltimore longitudinal study of aging. 104
Brugada syndrome and syncope: A systematic review 103
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 102
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study 101
Very Short vs. Long Dual Antiplatelet Therapy after Second Generation Drug-eluting Stents in 35,785 Patients undergoing Percutaneous Coronary Interventions: a Meta-analysis of Randomised Controlled Trials 100
[Clinical studies of cardiac cell therapy in Italy] 97
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium–glucose co-transporter 2 inhibitors? 97
Pulmonary and cardiac drugs: clinically relevant interactions 96
Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: Lessons from the coronavirus disease 2019 lockdown in Italy 96
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 94
Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy 94
Reply: The Barcelona Bio-HF Calculator: A Contemporary Web-Based Heart Failure Risk Score 94
Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent implantation: a network Meta-analysis 94
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 93
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 93
Effect of statin treatment on arterial stiffness in individuals with newly-diagnosed Heterozygous Familial Hypercholesterolemia. 92
Totale 14.643
Categoria #
all - tutte 59.859
article - articoli 56.901
book - libri 0
conference - conferenze 2.958
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.148 31 28 73 106 46 108 63 276 83 117 35 182
2022/20231.246 117 119 24 122 193 186 17 88 201 10 152 17
2023/2024780 34 92 17 108 74 108 49 59 51 29 46 113
2024/20252.611 89 174 59 168 362 271 259 430 134 118 253 294
2025/20265.344 576 262 469 463 556 360 791 228 320 515 383 421
2026/2027425 425 0 0 0 0 0 0 0 0 0 0 0
Totale 16.882